Pharmaceutical & Biotech

HomeCasesPharmaceutical & Biotech
Sole Arbitrator
CPR International Institute
Dispute involving a nine figure private investment placed by a private investment fund in a publicly traded pharmaceutical company for the research and development of a specific medical device, alleged damages in excess of US$ 150 million
Chair
American Arbitration Association
Dispute involving two biotechnology companies and claim for breach of development and license agreement of a genomic database software project, alleged damages in excess of US$ 30 million
Chair
CPR International Institute
Dispute between two pharmaceutical companies concerning a patent for coronary stent technology, amount in dispute in excess of US$ 450 million
Chair
American Arbitration Association
Dispute between two multinational agricultural conglomerates concerning patents for bioengineering of plant material and related trademarks, alleged damages in excess of US$ 300 million
Sole Appellate Arbitrator
CPR International Institute
Appeal of a three-person panel award concerning the license of a patented monoclonal antibody intended for the treatment of diabetes, alleged damages in excess of US$100 million